Òscar Reig
-
- Cancer Genomics and Diagnostics 9
- Cancer, Lipids, and Metabolism 6
-
- Prostate Cancer Treatment and Research 20
- Renal cell carcinoma treatment 15
-
- Cancer Immunotherapy and Biomarkers 11
-
- Renal and related cancers 8
-
- Radiopharmaceutical Chemistry and Applications 10
-
- Bladder and Urothelial Cancer Treatments 8
- Co-authors
- Begoña MelladoNatàlia JiménezMercedes Marín‐AguileraPedro L. FernándezAleix PratAlbert FontJuan José LozanoLourdes Mengual
- Journals
- Journal of Clinical Oncology (19 papers)Cancer Research (3 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Òscar Reig
47 papers receiving 558 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 153
- Pulmonary and Respiratory Medicine 303
- Oncology 218
- Endocrinology, Diabetes and Metabolism 66
- Molecular Biology 190
Countries citing papers authored by Òscar Reig
This map shows the geographic impact of Òscar Reig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Òscar Reig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Òscar Reig more than expected).
Fields of papers citing papers by Òscar Reig
This network shows the impact of papers produced by Òscar Reig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Òscar Reig. The network helps show where Òscar Reig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Òscar Reig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 18 | |
| 15 | 2020 | 0 | |
| 16 | 2020 | 10 | |
| 17 | 2016 | 63 | |
| 18 | 2015 | 18 | |
| 19 | 2014 | 123 | |
| 20 | 2014 | 19 |
About Òscar Reig
Òscar Reig is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 56 papers that have together received 562 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (20 papers), Renal cell carcinoma treatment (15 papers), Cancer Immunotherapy and Biomarkers (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Genomics and Diagnostics (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Renal and related cancers (8 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Cancer Research (153 citations), Pulmonary and Respiratory Medicine (303 citations) and Oncology (218 citations). Òscar Reig has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Begoña Mellado, Natàlia Jiménez, Mercedes Marín‐Aguilera, Pedro L. Fernández, Aleix Prat, Albert Font, Juan José Lozano, Lourdes Mengual, Antonio Alcaraz and María J. Ribal. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.